NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Anthropic Scales Back Warning on Unauthorized Trading Platforms

In a move that has alleviated concerns among investors, Anthropic, the AI startup behind Claude-maker, has revised its warning regarding the secondary-market trading of its shares. The company has reduced the number of unauthorized trading platforms it identified from eight to four. This revision comes after the original notice sparked a strong reaction from one of the firms mentioned, according to Bloomberg.

In its initial blog post, Anthropic listed eight companies that it claimed were facilitating the purchase or sale of its shares without approval and in breach of the company's transfer restrictions. The firm warned that any such transactions would be considered invalid and would not be recorded in its shareholder register. The restriction applied to both common and preferred shares. However, the updated blog post now names only four platforms: Open Door Partners, Unicorns Exchange, Pachamama, and Upmarket.

The removal of several well-known participants in the private-share trading market from the earlier version has been a significant development. The updated notice from Anthropic explicitly states that "any sale or transfer of Anthropic stock, or any interest in Anthropic stock, offered by these firms is void and will not be recognized on our books and records."

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The initial notice from Anthropic sparked confusion and concern among investors, highlighting restrictions on unauthorized share transactions that both the company and rival OpenAI have long maintained. While such restrictions were often overlooked by investors eager to gain exposure to fast-growing AI firms, the situation escalated when Anthropic took the uncommon step of publicly identifying specific trading platforms.

The announcement led to a decline in the value of publicly traded funds offering exposure to Anthropic, while participants in the private-share market faced significant disruption. Hiive CEO Sim Desai pushed back against the allegations, stating that his platform does not enable share transfers without the company's approval. After Hiive was removed from the updated list, Desai claimed that the original warning had created uncertainty among investors and harmed the company's reputation.

PlatformRemoved from List
HiiveYes
Other firmsNo

The disagreement comes at a time of intense investor interest in Anthropic. On Thursday, the company announced a new funding round that raised $65 billion and valued the AI startup at $965 billion, including the fresh capital. The valuation surpassed that of OpenAI for the first time, underscoring Anthropic's rapid rise in the artificial intelligence sector.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should be aware of the revised list of unauthorized share trading platforms and ensure compliance with company transfer restrictions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.